volume 31 issue 3 pages 1069-1093

Curcumin and chemokines: mechanism of action and therapeutic potential in inflammatory diseases

Mahvash Sadeghi 1
Sajad Dehnavi 2, 3
Ali Asadirad 2
Suowen Xu 4
Muhammed Majeed 5
Tannaz Jamialahmadi 6, 7
Thomas P. Johnston 8
Amirhossein Sahebkar 7, 9, 10, 11
Publication typeJournal Article
Publication date2023-03-30
scimago Q1
wos Q1
SJR1.269
CiteScore8.4
Impact factor5.3
ISSN09254692, 15685608
Pharmacology
Pharmacology (medical)
Immunology
Abstract
Chemokines belong to the family of cytokines with chemoattractant properties that regulate chemotaxis and leukocyte migration, as well as the induction of angiogenesis and maintenance of hemostasis. Curcumin, the major component of the Curcuma longa rhizome, has various pharmacological actions, including anti-inflammatory, immune-regulatory, anti-oxidative, and lipid-modifying properties. Chemokines and chemokine receptors are influenced/modulated by curcumin. Thus, the current review focuses on the molecular mechanisms associated with curcumin's effects on chemoattractant cytokines, as well as putting into context the many studies that have reported curcumin-mediated regulatory effects on inflammatory conditions in the organs/systems of the body (e.g., the central nervous system, liver, and cardiovascular system). Curcumin's effects on viral and bacterial infections, cancer, and adverse pregnancy outcomes are also reviewed.
Found 
Found 

Top-30

Journals

1
2
3
4
5
Frontiers in Pharmacology
5 publications, 5%
Naunyn-Schmiedeberg's Archives of Pharmacology
4 publications, 4%
Inflammopharmacology
4 publications, 4%
Pathology Research and Practice
3 publications, 3%
Journal of Drug Delivery Science and Technology
2 publications, 2%
Frontiers in Immunology
2 publications, 2%
PLoS ONE
2 publications, 2%
Current Issues in Molecular Biology
2 publications, 2%
Pharmacological Research
2 publications, 2%
Pharmaceuticals
2 publications, 2%
Endocrine, Metabolic and Immune Disorders - Drug Targets
2 publications, 2%
Biochemical and Biophysical Research Communications
2 publications, 2%
Biomedicine and Pharmacotherapy
1 publication, 1%
Nutrients
1 publication, 1%
International Journal of Pharmaceutics
1 publication, 1%
Journal of Biomolecular Structure and Dynamics
1 publication, 1%
OncoTargets and Therapy
1 publication, 1%
Cancers
1 publication, 1%
Frontiers in Oncology
1 publication, 1%
European Journal of Pharmaceutics and Biopharmaceutics
1 publication, 1%
Foods
1 publication, 1%
Archives of Toxicology
1 publication, 1%
Phytomedicine
1 publication, 1%
Biomedical Technology
1 publication, 1%
Mechanisms of Ageing and Development
1 publication, 1%
Current Problems in Cardiology
1 publication, 1%
Pharmaceutics
1 publication, 1%
Expert Opinion on Drug Safety
1 publication, 1%
Molecular Medicine Reports
1 publication, 1%
1
2
3
4
5

Publishers

5
10
15
20
25
30
Elsevier
28 publications, 28%
Springer Nature
19 publications, 19%
MDPI
15 publications, 15%
Frontiers Media S.A.
12 publications, 12%
Taylor & Francis
6 publications, 6%
Wiley
5 publications, 5%
Bentham Science Publishers Ltd.
4 publications, 4%
Public Library of Science (PLoS)
2 publications, 2%
Ovid Technologies (Wolters Kluwer Health)
2 publications, 2%
Spandidos Publications
1 publication, 1%
American Chemical Society (ACS)
1 publication, 1%
Faculdade de Medicina da Universidade de Sao Paulo
1 publication, 1%
Oxford University Press
1 publication, 1%
SAGE
1 publication, 1%
Baishideng Publishing Group
1 publication, 1%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 1%
5
10
15
20
25
30
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
100
Share
Cite this
GOST |
Cite this
GOST Copy
Sadeghi M. et al. Curcumin and chemokines: mechanism of action and therapeutic potential in inflammatory diseases // Inflammopharmacology. 2023. Vol. 31. No. 3. pp. 1069-1093.
GOST all authors (up to 50) Copy
Sadeghi M., Dehnavi S., Asadirad A., Xu S., Majeed M., Jamialahmadi T., Johnston T. P., Sahebkar A. Curcumin and chemokines: mechanism of action and therapeutic potential in inflammatory diseases // Inflammopharmacology. 2023. Vol. 31. No. 3. pp. 1069-1093.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1007/s10787-023-01136-w
UR - https://doi.org/10.1007/s10787-023-01136-w
TI - Curcumin and chemokines: mechanism of action and therapeutic potential in inflammatory diseases
T2 - Inflammopharmacology
AU - Sadeghi, Mahvash
AU - Dehnavi, Sajad
AU - Asadirad, Ali
AU - Xu, Suowen
AU - Majeed, Muhammed
AU - Jamialahmadi, Tannaz
AU - Johnston, Thomas P.
AU - Sahebkar, Amirhossein
PY - 2023
DA - 2023/03/30
PB - Springer Nature
SP - 1069-1093
IS - 3
VL - 31
PMID - 36997729
SN - 0925-4692
SN - 1568-5608
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2023_Sadeghi,
author = {Mahvash Sadeghi and Sajad Dehnavi and Ali Asadirad and Suowen Xu and Muhammed Majeed and Tannaz Jamialahmadi and Thomas P. Johnston and Amirhossein Sahebkar},
title = {Curcumin and chemokines: mechanism of action and therapeutic potential in inflammatory diseases},
journal = {Inflammopharmacology},
year = {2023},
volume = {31},
publisher = {Springer Nature},
month = {mar},
url = {https://doi.org/10.1007/s10787-023-01136-w},
number = {3},
pages = {1069--1093},
doi = {10.1007/s10787-023-01136-w}
}
MLA
Cite this
MLA Copy
Sadeghi, Mahvash, et al. “Curcumin and chemokines: mechanism of action and therapeutic potential in inflammatory diseases.” Inflammopharmacology, vol. 31, no. 3, Mar. 2023, pp. 1069-1093. https://doi.org/10.1007/s10787-023-01136-w.